0000899243-18-031089.txt : 20181214 0000899243-18-031089.hdr.sgml : 20181214 20181214163334 ACCESSION NUMBER: 0000899243-18-031089 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181213 FILED AS OF DATE: 20181214 DATE AS OF CHANGE: 20181214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PIKOVER YURI CENTRAL INDEX KEY: 0001032389 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32157 FILM NUMBER: 181235974 MAIL ADDRESS: STREET 1: C/O XLAN CORP STREET 2: 26679 WEST AGOURA ROAD CITY: CALABASAS STATE: CA ZIP: 91302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Savara Inc CENTRAL INDEX KEY: 0001160308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841318182 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 S. CAPITAL OF TEXAS HIGHWAY STREET 2: SUITE 150 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 512-614-1848 MAIL ADDRESS: STREET 1: 900 S. CAPITAL OF TEXAS HIGHWAY STREET 2: SUITE 150 CITY: AUSTIN STATE: TX ZIP: 78746 FORMER COMPANY: FORMER CONFORMED NAME: Mast Therapeutics, Inc. DATE OF NAME CHANGE: 20130312 FORMER COMPANY: FORMER CONFORMED NAME: ADVENTRX PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030613 FORMER COMPANY: FORMER CONFORMED NAME: BIOKEYS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20010928 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-12-13 0 0001160308 Savara Inc SVRA 0001032389 PIKOVER YURI 6836 BEE CAVE ROAD, BUILDING III SUITE 200 AUSTIN TX 78746 1 0 0 0 Stock Option (Right to Buy) 7.33 2018-12-13 4 A 0 12000 0.00 A 2028-12-13 Common Stock 12000 12000 D The shares subject to the option vest and become exercisable in twelve equal installments on each quarterly anniversary of December 13, 2018, subject to the reporting person's continued service with the Issuer. /s/ David Lowrance as attorney-in-fact for Yuri Pikover 2018-12-14